Cellectis (CLLS) Accumulated Expenses: 2014-2023
Historic Accumulated Expenses for Cellectis (CLLS) over the last 7 years, with Jun 2023 value amounting to $7.1 million.
- Cellectis' Accumulated Expenses fell 25.96% to $7.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $7.1 million, marking a year-over-year decrease of 25.96%. This contributed to the annual value of $9.4 million for FY2022, which is N/A change from last year.
- According to the latest figures from Q2 2023, Cellectis' Accumulated Expenses is $7.1 million, which was up 26.50% from $5.6 million recorded in Q1 2023.
- Cellectis' Accumulated Expenses' 5-year high stood at $13.0 million during Q4 2020, with a 5-year trough of $4.0 million in Q1 2019.
- Moreover, its 3-year median value for Accumulated Expenses was $9.5 million (2021), whereas its average is $8.7 million.
- Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 80.67% in 2021, then crashed by 30.48% in 2023.
- Over the past 5 years, Cellectis' Accumulated Expenses (Quarterly) stood at $7.3 million in 2019, then skyrocketed by 77.78% to $13.0 million in 2020, then climbed by 14.39% to $10.8 million in 2021, then climbed by 0.62% to $9.4 million in 2022, then dropped by 25.96% to $7.1 million in 2023.
- Its last three reported values are $7.1 million in Q2 2023, $5.6 million for Q1 2023, and $9.4 million during Q4 2022.